Taiwan Liposome Company, Ltd.
DelistedCIK 1722890fmd_0HJJE0YE0X0YWQ4NKZ76R4NAA1Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2016 to Dec 31, 2020, 5 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|
| Total revenues | 42 | 50 | 62 | 209 | 102 |
| Research and development | 737 | 813 | 833 | 860 | 968 |
| Operating income | (831) | (877) | (892) | (802) | (983) |
| Interest expense | 3 | 3 | 10 | 24 | 17 |
| Income before taxes | (824) | (873) | (901) | (803) | (982) |
| Income tax expense | 1 | 1 | 1 | 4 | 1 |
| Net income from continuing operations | (824) | (874) | (902) | (808) | (983) |
| Net income | (824) | (874) | (902) | (808) | (982) |
| Net income to common shareholders | (824) | 874 | (902) | (808) | (982) |